Darbepoetin alfa (rINN) /dɑrbəˈpɔɪtɨn/ is a synthetic form of erythropoietin. It
stimulates erythropoiesis (increases red blood cell levels) and is used to treat .....
Clinical studies have shown darbepoetin alfa (albumin) to increase the risk of
serious side effects (eg, blood clots, stroke, heart attack, heart failure) and death
Manufacturer provides indications, side effects, contraindications and
mechanisms of action of this treatment for anemia associated with chronic renal
failure and ...
It is a clear liquid that can be given through an intravenous infusion (IV), or as a shot.
Chemotherapy for breast cancer affects all the rapidly dividing cells in your body, including bone marrow cells -- which produce white and red blood cells -- and platelets. An ... More »
Apr 16, 2014 ... Consumer information about the medication DARBEPOETIN ALFA - INJECTION (
Aranesp), includes side effects, drug interactions, ...
Mar 15, 2012 ... Using darbepoetin alfa injection increases the risk that blood clots will form in or
move to the legs, lungs, or brain. Tell your doctor if you have or ...
Darbepoetin alfa injection causes the bone marrow to produce red blood cells. If
the body does not produce enough red blood cells, severe anemia can occur.
ARANESP® (darbepoetin alfa) injection, for intravenous or subcutaneous use.
Initial U.S. Approval: 2001. WARNING: ESAs INCREASE THE RISK OF DEATH,.
Drug type: Darbepoetin alfa is a biologic response modifier. It is an erythropoiesis
stimulating protein. (For more detail, see "How this drug works" section below).